skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparison of Herpes simplex virus plaque development after viral treatment with anti-DNA or antilipid agents

Journal Article · · Biophys. J.; (United States)

The plaque development of Herpes simplex virus type 1 (HSV) is slower for viruses treated with two anti-DNA agents: ultraviolet radiation (uv) or n-acetoxy-2-acetyl-aminofluorene. For HSV treated with three antimembrane agents - butylated hydroxytoluene, acridine plus near uv radiation, or ether - the plaque development time is the same as for untreated viruses. These differences hold even for viruses that survived treatment that lowered viability below the 1% level. Gamma ray inactivation of HSV produces no change in plaque development even though this agent is believed to preferentially affect viral DNA.

Research Organization:
Western Kentucky Univ., Bowling Green
OSTI ID:
5126268
Journal Information:
Biophys. J.; (United States), Vol. 30:3
Country of Publication:
United States
Language:
English

Similar Records